Advanced Medical Solutions Group plc (AIM:AMS)

Market Cap	535.38M +36.5%
Revenue (ttm)	228.94M +29.0%
Net Income	9.95M +40.3%
EPS	0.05 +39.1%
Shares Out	216.31M
PE Ratio	54.76
Forward PE	19.09
Dividend	0.03 (1.16%)
Ex-Dividend Date	May 28, 2026

Volume	184,318
Average Volume	1,283,861
Open	243.00
Previous Close	247.50
Day's Range	243.00 - 248.88
52-Week Range	185.60 - 272.00
Beta	0.72
RSI	62.17
Earnings Date	Jun 16, 2026

About AIM:AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and Acti...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 1,500
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2025, AIM:AMS's revenue was 228.94 million, an increase of 28.96% compared to the previous year's 177.52 million. Earnings were 9.95 million, an increase of 40.32%.